Case Study: Top 20 Biopharmaceutical Company builds a stronger hyperkalemia advocacy strategy with OrangeFiery

Top 20 Biopharmaceutical Company establishes relationships with all top-tier advocacy groups with OrangeFiery

The customer, a top 20 biopharmaceutical company, faced the challenge of understanding the patient advocacy landscape as it prepared to launch a new therapy for hyperkalemia. It needed to identify how to best reach at-risk patients in the chronic kidney disease, heart failure, and diabetes communities and required a strategy for operationalizing advocacy engagement. The company engaged the vendor OrangeFiery for its advocacy engagement services.

OrangeFiery conducted a comprehensive landscape assessment to identify and rank the most influential advocacy groups. They then developed and deployed a strategic engagement plan, which included establishing internal policies and conducting outreach. This resulted in established relationships with all top-tier advocacy organizations, updated educational materials from the National Kidney Foundation, and unique partnerships that increased focus on the disease.

Top 20 Biopharmaceutical Company